deltatrials
Completed NA NCT00588380

GLP1R Polymorphisms and Response to GLP1

A Pilot Study Examining How Common Genetic Variation in GLP1R Alters Response to GLP1 Infusion

Sponsor: Mayo Clinic

Conditions Diabetes
Interventions GLP-1
Updated 10 times since 2017 Last updated: Dec 14, 2011 Started: Nov 30, 2007 Primary completion: Sep 30, 2010 Completion: Sep 30, 2010

Listed as NCT00588380, this NA trial focuses on Diabetes and remains completed. Sponsored by Mayo Clinic, it has been updated 10 times since 2007, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2023 — Jul 2024 [monthly]

    Completed NA

  4. Dec 2022 — Jan 2023 [monthly]

    Completed NA

  5. Jun 2022 — Dec 2022 [monthly]

    Completed NA

▶ Show 5 earlier versions

  1. Dec 2021 — Jun 2022 [monthly]

    Completed NA

  2. Jan 2021 — Dec 2021 [monthly]

    Completed NA

  3. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  4. Feb 2017 — Jun 2018 [monthly]

    Completed NA

  5. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mayo Clinic
  • Merck Sharp & Dohme LLC
Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Rochester, United States